NASDAQ: TRIB
Trinity Biotech PLC Stock Ownership - Who owns Trinity Biotech?

Insider buying vs selling

Have Trinity Biotech PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TRIB insiders and whales buy or sell their stock.

TRIB Shareholders

What type of owners hold Trinity Biotech PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ronan Ocaoimh3.90%486,208$2.77MInsider
Williams Novak LLC1.13%140,543$801.10kInstitution
John Gillard0.08%10,000$57.00kInsider
Hunter0.01%661$3.77kInstitution
Hunter Associates Investment Management LLC0.01%661$3.77kInstitution
Wilnov0.00%141$803.70Institution
Williams Novak Wealth Management LLC0.00%140$798.00Institution
Susque0.00%27$153.90Institution
Mosdam0.00%26$148.20Institution
Susquehanna International Group LLP0.00%26$148.20Institution

1 of 3

TRIB vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRIB0.01%3.98%
ADVB0.00%0.00%Net Selling
VNRX0.00%100.00%Net SellingNet Selling
MBAI0.00%100.00%
BIAF0.02%99.98%

Trinity Biotech Stock Ownership FAQ

Who owns Trinity Biotech?

Trinity Biotech (NASDAQ: TRIB) is owned by 0.01% institutional shareholders, 3.98% Trinity Biotech insiders, and 96.01% retail investors. Ronan Ocaoimh is the largest individual Trinity Biotech shareholder, owning 486,208.00 shares representing 3.90% of the company. Ronan Ocaoimh's Trinity Biotech shares are currently valued at $2.77M.

If you're new to stock investing, here's how to buy Trinity Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.